Corient Private Wealth
TECH icon

Corient Private Wealth’s Bio-Techne TECH Stock Holding History

Corient Private Wealth’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.65M Buy
122,377
+97,138
+385% +$5.25M 0.01% 698
2026
Q1 		$1.28M Sell
25,239
-254,584
-91% -$15.3M ﹤0.01% 1500
2025
Q4 		$16.5M Sell
279,823
-198,406
-41% -$12.1M 0.02% 442
2025
Q3 		$26.6M Buy
478,229
+104,036
+28% +$5.57M 0.04% 337
2025
Q2 		$19.3M Sell
374,193
-38,565
-9% -$1.94M 0.03% 395
2025
Q1 		$24.2M Sell
412,758
-186,160
-31% -$12.6M 0.04% 361
2024
Q4 		$43.1M Sell
598,918
-38,188
-6% -$2.8M 0.07% 247
2024
Q3 		$50.9M Buy
637,106
+25,261
+4% +$1.9M 0.08% 238
2024
Q2 		$43.8M Sell
611,845
-14,001
-2% -$1.03M 0.08% 247
2024
Q1 		$44.1M Sell
625,846
-7,944
-1% -$568K 0.08% 243
2023
Q4 		$48.9M Buy
633,790
+619,958
+4,482% +$40.8M 0.09% 219
2023
Q3 		$942K Sell
13,832
-5,775
-29% -$456K ﹤0.01% 1213
2023
Q2 		$1.6M Buy
19,607
+6,628
+51% +$533K ﹤0.01% 977
2023
Q1 		$965K Sell
12,979
-10,386
-44% -$800K ﹤0.01% 1101
2022
Q4 		$2.05M Buy
+23,365
New +$1.86M 0.01% 698

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Corient Private Wealth's TECH Position: Q2 2026 in Review

Corient Private Wealth increased its Bio-Techne (TECH) stake by 385% in Q2 2026, buying an estimated $5.25M and bringing the position to 122,377 shares worth $8.65M. The position accounts for 0.01% of the portfolio, ranked #698.

Corient Private Wealth first reported a position in TECH in Q4 2022 and has held it in 15 quarters since. The position peaked at $50.9M in Q3 2024. 593 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Corient Private Wealth held 122,377 shares of Bio-Techne worth $8.65M as of Q2 2026.
  • Corient Private Wealth bought 97,138 Bio-Techne shares in Q2 2026, an estimated $5.25M.
  • Bio-Techne made up 0.01% of Corient Private Wealth's portfolio in Q2 2026, its #698 holding.
  • Corient Private Wealth first reported a position in Bio-Techne in Q4 2022 and has held it in 15 quarters since.
  • Corient Private Wealth's Bio-Techne position peaked at $50.9M in Q3 2024.
  • 593 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.